clearly positive with lactoferrin controls), coarse agglutination with the control antibody as provided by TechLab might provide a clue that breast milk may be present in the specimen.
In conclusion, our experience and experiences in several other laboratories would certainly concur with that of Quiroga and colleagues; fecal lactoferrin appears to be a more sensitive test than fecal leukocytes in the evaluation of patients with acute diarrhea. However, as with any laboratory test, this should be interpreted in the context of the clinical presentation (which, with fecal lactoferrin, may include the possibility of false positives with breast-fed infants when tested with certain antibodies). Corynebacterium urealyticum, formerly known as Corynebacterium group D2, is a new species in the genus Corynebacterium (3) which has been involved mainly in urinary tract infections but also in endocarditis, pneumonia, peritonitis, osteomyelitis, and soft-tissue infections (1, 5, 6 ). The clinical significance of most organisms isolated from normally sterile sites such as the kidney, the bladder wall, the ureter, and blood is relatively easy to determine. However, that of organisms isolated from nonsterile areas, such as urine or sputum, is more difficult to assess.
Ryan and Murray (4) have recently examined the value of selective media for isolation of C. urealyticum from urine samples as well as determination of the clinical relevance of such isolates. They studied 194 urine samples which had pHs of .7.0, finding two isolates of C. urealyticum (prevalence, 1% in urine samples with such a pH) which were not related to the urinary tract infectin symptoms. This finding partially confirms those of a previously published paper which included more than 9,000 unselected urine samples showing a prevalence of 1.17% with selective media but only 0.038% with nonselective media (7). Unsurprisingly, most or all of the 15 organisms isolated from 13 patients by using selective media were not involved in the clinical symptoms, but those isolated from three patients by using nonselective media were (7). De Briel et al. (2) , by studying more than 5,000 unselected urine samples, isolated C. urealyticum in 2.5% (2105 CFU/ml) of the urine samples using selective and nonselective culture media (2). Our rates of C. urealyticum isolation from unselected urine samples are 1.9 and 0.23% with selective and nonselective media, respectively. Again, up to 60% of isolates from nonselective medium were clinically significant (5); the rate for those isolates from selective medium was very low (unpublished data). Selective medium for isolating C. urealyticum from urine samples has great epidemiological value, but it is not useful for management of the patients, as most strains isolated only from selective medium have no clinical relevance.
The decision to look for C. urealyticum in urine specimens and therefore to extend the incubation of urine cultures is a matter open for discussion. Nevertheless, we do not recommend the use of selective media for routine purposes. We recommend cystine lactose electrolyte-deficient and blood agars instead. Several circumstances, such as kind of hospital, local prevalence, data from urine sediment, and above all, clinical information communicated to the microbiologist, as also stated by Ryan and Murray (4) 
